Heart Failure-USB: Prediction and Progression
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 6,000
- 试验地点
- 1
- 主要终点
- number of all-cause death
研究概览
简要总结
This retrospective cohort study is to identify triggers of heart failure (HF) development and drivers of HF progression as well as the underlying cardiac disease (phenotype) to identify patients at risk and predict the clinical course of the disease. Data of patients who were hospitalized during the years 2010-2023 with acute coronary syndrome (ACS) and/ or with acute heart failure (AHF) will be collected and analyzed. In a subgroup cohort efficacy and safety of digoxin in patients with acute heart failure triggered by tachyarrhythmia will be evaluated.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients hospitalized with a primary diagnosis of ACS
- •Patients hospitalized with a primary or secondary diagnosis of AHF
排除标准
- •Existence of a documented statement of the patient against the scientific use of clinical data
结局指标
主要结局
number of all-cause death
时间窗: 1 to 8 years after hospitalization
number of all-cause death in patients hospitalized with ACS and AHF during the years 2010-2023.
number of cardiovascular hospitalizations
时间窗: 1 to 8 years after hospitalization
number of cardiovascular hospitalizations
number of HF hospitalizations
时间窗: 1 to 8 years after hospitalization
number of new HF hospitalizations in patients hospitalized with ACS and AHF during the years 2010-2023
number of cardiovascular death
时间窗: 1 to 8 years after hospitalization
number of cardiovascular death in patients hospitalized with ACS and AHF
次要结局
未报告次要终点